Holographic Film Market Segmented By Transparent, Metallized Film Type with BOPET, BOPP, PVC Material for Decorative, Anti-counterfeit in Generic, Customized Offering
Industry: Chemicals and Materials
Published Date: December-2016
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 293
Report ID: PMRREP12892
The global holographic film market is estimated to grow at a robust pace by the end of 2027, creating wide spaces of growth for the market players. High demand for packaging across different sectors is expected to drive this growth in the coming years. Accelerating demand for films embossed with security code is expected to boost the market expansion in the coming years. The pharmaceutical industry is estimated to surface as the leading end-use by the end of the forecast period.
The dull growth of different sectors including the packaging sector during COVID-19 is expected to deter the high growth rate of the market, negatively influencing the market size. The market is expected to restore its growth rate with relaxations in lockdown.
Buoyed by the high adoption rate of advanced hologram technologies, the market in North America is expected to grow at a rapid pace in the coming years. Regions such as Asia Pacific, Middle East, and Africa are projected to exhibit fast-paced market growth through the forecast period. Established players in the global market include Nan Ya Plastics Corporation, Cosmo Films Limited, K LASER Technology Inc., Toray Industries, Inc., and Uflex Limited.
The global pharmaceutical segment is one of the rising industries which has successfully established its own entity in the global economy and is expected to surge in the forthcoming years. The worth of the global pharmaceutical packaging industry has grown manifold in the last few years. A massive wave of digitization has completely changed the face of the pharmaceutical industry in the last few years. Several advanced apps and varied digital platforms have escalated the end–user experience in many ways.
The rapid rise of counterfeit drugs has barricaded the pharmaceutical industry growth. The soaring population of counterfeit drugs are crippling the pharmaceutical industry by establishing a parallel economy. There are several long-term and short-term impacts of counterfeit drugs that are paralyzing the pharmaceutical industry. This emerging issue of counterfeit drugs is a massive challenge for the pharmaceutical industry.
Medicine companies around the world are fighting hard to create proper and robust systems to counter the growth of counterfeit drugs. Pharma companies are rapidly incorporating new techniques to build a full proof packaging system to arrest the expansion of these forged drugs. The demand for holographic films will spike in the FMCG and medicine industry.
The holographic films can produce proper holographic tags that possess a unique counterfeit quality. The global holographic films market is expected to be valued more than US$ 11,000 Mn by the end of 2024. The sales revenue is estimated to increase at a CAGR of 9.3%. FMCG and Pharmaceuticals segments in the end use industry are projected to be the fastest growing segments, registering CAGR of 10.2% and 10.5% over the forecast period.
Asia Pacific accounts for the higher market share and is expected to witness rapid growth over the forecast period. North America and Europe are more inclined towards anti-counterfeit applications. Companies’ investments in these regions should focus more on products dealing with counterfeits.
North America and Europe are expected to exhibit an attractiveness index of 0.8 and 0.7 respectively. Both these regions have robust holographic technologies and are hence matured in comparison to the Asian market. Also, these regions are more inclined towards the use of holographic films in anti-counterfeit applications.
Increasing shelf impact along with brand protection on consumer goods is expected to fuel demand for various end use companies. The high competition in FMCG goods is expected to boost the global holographic films market growth. In terms of value, the pharmaceuticals segment is estimated to be valued at more than US$ 1,200 Mn by 2016 end and is projected to cross US$ 2,700 Mn by 2024 end, exhibiting a CAGR of 10.5 % over the forecast period. In terms of value, pharmaceuticals segment is expected to increase to 2.2X over the forecast period.
Pharmaceuticals segment is estimated to showcase a proper growth within the period of assessment. This segment of the global holographic films market will likely create total incremental opportunity of more than US$ 1,500 Mn between 2016 and 2024. By end use industry, FMCG and pharmaceuticals segments are expected to emerge as the most attractive segments in terms of CAGR and market share during the forecast period.
APAC region is expected to emerge as the most attractive segment in terms of CAGR and market share during the forecast period. The holographic films market in APAC is mostly driven by the end use industries such as food & beverage and FMCG. The countries such as China and India are the major contributors in the APAC region both in terms of production and consumption.
Pharmaceutical segment is estimated to account for major value share of 22.1% by the end of 2016 and is expected to gain 290 BPS to account for 24.9% share by 2024 end in Latin America. Pharmaceutical segment is anticipated to emerge as the most attractive segment in Latin America within the forecast period.
In Europe, in terms of value, the pharmaceuticals segment is expected to register a significantly high CAGR of 10.7% over the forecast period. Revenue contribution of this segment to the Europe holographic films market is estimated to account for 22.1% share by 2016 end and is expected to gain 330 BPS over the forecast period. In the APAC region in terms of value, pharmaceuticals segment is expected to register a CAGR of 11% over the forecast period.
|
By Film Type |
|
|
By Material Type |
|
|
By Application
|
|
|
By Offering |
|
|
By End Use |
|
|
By End Use Industry |
|
|
By Regions |
|
To know more about delivery timeline for this report Contact Sales
